About the brand ❤️
Isomorphic Labs is a UK-based artificial intelligence and drug discovery company focused on transforming the process of biomedical research through cutting-edge AI technologies. Founded in 2021 by Demis Hassabis and established as a subsidiary of Alphabet Inc., the company builds on DeepMind’s Nobel Prize-winning protein-prediction AI AlphaFold to accelerate the design of novel therapeutics. Its headquarters are in London, and the company has expanded with offices in Lausanne and Cambridge, Massachusetts, reflecting its global ambitions. Isomorphic Lab’s mission centers on creating a new AI-driven paradigm for discovering and designing drugs, aiming to dramatically reduce the time and cost associated with traditional pharmaceutical development. It has secured significant external funding and formed partnerships with major pharmaceutical firms, pushing the frontiers of digital biology and predictive AI models. As a research-intensive venture under Alphabet, Isomorphic continues to grow its capabilities, recruit interdisciplinary experts, and advance programs across multiple therapeutic areas with the goal of enabling next-generation precision medicines.
Founded: 2021
Headquarters:
London, England, United Kingdom of Great Britain and Northern Ireland (the)
Owner: Alphabet Inc.
https://www.isomorphiclabs.com/
Download PNG
